Roxee Meds Catalog

Flunixin Meglumine

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog complete Livestock/food-animal use Rx required Top Dressing In Feed Multiple FDA labelers Official label facts Owner quick guide first

Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Food-animal or livestock record. This source record is for livestock or food-animal use, not a dog/cat medication profile. Food-animal rules, withdrawal intervals, and residue restrictions may apply. Do not start, stop, or change treatment without your veterinarian.

Data freshness

Storefront facts

Catalog refreshed

May 5, 2026, 10:05 a.m.

These are the storefront facts Roxee uses on browse cards and quick facts.

FDA applications

FDA application data refreshed

May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports

No safety reports linked

No refresh timestamp yet

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details

Storefront facts: Source Roxee | Refreshed May 5, 2026, 10:05 AM UTC
The storefront fact projection used for browse cards and quick facts.
Animal Drugs @ FDA: Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: February 12, 2026

Updated: February 12, 2026, 10:44 PM UTC

Sources:

FDA application profile · official_label
FDA application profile · official_label
Medication usage source · fda_animal_drugs
Banamine® Paste · official_label
openFDA case USA-USFDACVM-2019-US-025839 · adverse_reaction

Image coming soon

Flunixin Meglumine

Drug type: Food-animal record • Branded profile • Livestock/food-animal use

Both Top Dressing In Feed Rx required 100% storefront ready

Species: Both

Approval status: Food-animal or livestock record. This source record is for livestock or food-animal use, not a dog/cat medication profile. Food-animal rules, withdrawal intervals, and residue restrictions may apply.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Flunixin Meglumine

For alleviation of inflammation and pain associated with musculoskeletal disorders, and alleviation of visceral pain associated with colic. For control of pyrexia associated with bovine respiratory disease, acute bovine mastitis, and endotoxemia. Also indicated for control of inflammation in endotoxemia. For the control of pyrexia associated with swine respiratory disease. Species commonly shown: Both, Horse, Not For Meat Production, Beef, excluding breeding bulls.

Generic name

Flunixin Meglumine

Brand names

Banamine® Granules, Banamine® Banamine®-S, Banamine® Paste, Flu-Nix™

Manufacturer

Multiple FDA labelers

Species

Both, Horse, Not For Meat Production, Beef, excluding breeding bulls, Dairy, excluding dry dairy cows and breeding bulls

Dosage forms

Top Dressing In Feed, Injectable Solution, Paste, Liquid (Solution)

Prescription

Prescription required

Completeness

100%

Validation

Complete

Brand names

Banamine® Granules Banamine® Banamine®-S Banamine® Paste Flu-Nix™ Flunixin Meglumine Injection Flunixin Meglumine Solution Flunazine™ Flunixin Injection - S Flunazine®-S Flunazine® Flunine™ Flunine-S™ Flunixin-S Banamine Prevail VetaMeg Flunixin Flunazine Flunine Flunixin Meglumine Flu-Nix Vetameg S Flunazine-S

Dosage forms

Top Dressing In Feed Injectable Solution Paste Liquid (Solution)

Indications / Uses

Warnings / Contraindications

Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not slaughter for human consumption within 4 days of last treatment. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Do not use in dry dairy cows. Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. Approved only for intravenous administration in cattle. Intramuscular administration has resulted in violative residues in the edible tissues of cattle sent to slaughter. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Swine must not be slaughtered for human consumption within 12 days of last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not slaughter for human consumption within 4 days of last treatment. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Do not use in dry dairy cows. Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. Approved only for intravenous administration in cattle. Intramuscular administration has resulted in violative residues in the edible tissues of cattle sent to slaughter. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Swine must not be slaughtered for human consumption within 12 days of last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

Top reported reactions (openFDA): Vomiting, Death, Diarrhoea, Elevated total bilirubin, Lack of efficacy - NOS, Lethargy (see also Central nervous system depression in 'Neurological').

FAQ

Both, Horse, Not For Meat Production, Beef, excluding breeding bulls, Dairy, excluding dry dairy cows and breeding bulls, Calves, excluding veal calves, Beef And Dairy, No Use Class Stated Or Implied, Dairy, excluding dry cows

Yes. Roxee shows this as prescription-only.

Top Dressing In Feed, Injectable Solution, Paste, Liquid (Solution)

Related Conditions

Mastitis Pain (acute, chronic)

Source Transparency

Verified source: https://www.roxee.ai/meds/
Verified source: https://animaldrugsatfda.fda.gov
Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
Verified source: https://api.fda.gov/animalandveterinary/event.json
Verified source: https://www.roxee.ai/conditions/
Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/864
Last refreshed: May 5, 2026, 10:05 a.m.
Last verified: Feb 12, 2026, 10:44 p.m.
Validation status: Complete

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

For the control of pyrexia associated with swine respiratory disease.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

Not for use in horses intended for food
Do not slaughter for human consumption within 4 days of last treatment
A withdrawal period has not been established for use in preruminating calves
Do not use in calves to be processed for veal
Do not use in dry dairy cows
Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food
Approved only for intravenous administration in cattle
Intramuscular administration has resulted in violative residues in the edible tissues of cattle sent to slaughter
Swine must not be slaughtered for human consumption within 12 days of last treatment
very low energy (1 reports)
Surgical site disorder (1 reports)
Shaking (1 reports)

When to call the vet:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.
Facial swelling or hives.
Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

Is this medicine the right fit for my pet’s current symptoms?
Which warning signs mean I should call back right away?
How should I handle missed doses or refusal to take the medicine?

Major cautions & emergency warning signs

Side effects to monitor:

Not for use in horses intended for food
Do not slaughter for human consumption within 4 days of last treatment
A withdrawal period has not been established for use in preruminating calves
Do not use in calves to be processed for veal
Do not use in dry dairy cows

Most reported reactions:

Tiredness (lethargy) (1 reports)
Surgical site disorder (1 reports)
Shaking (1 reports)

Emergency warning signs:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.

Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both

Manufacturer: Multiple FDA labelers

Form: Injectable Solution, Liquid (Solution), Paste, Top Dressing In Feed

Identifiers:

ANADA: 200061 ANADA: 200124 ANADA: 200142 ANADA: 200387 ANADA: 200476 ANADA: 200489 ANADA: 200581 ANADA: 200781 ANADA: 200791 ANADA: 200828 NADA: 101479 NADA: 106616 NADA: 137409 NADA: 141299 NADA: 141312 NDC Package: 0061-0214-02 NDC Package: 0061-0851-03 NDC Package: 0061-0851-04 NDC Package: 0061-4305-01 NDC Package: 0061-4305-02

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200489 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200791 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source

Warnings / Contraindications

High: Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not slaughter for human consumption within 4 days of last treatment. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Do not use in dry dairy cows. Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. Approved only for intravenous administration in cattle. Intramuscular administration has resulted in violative residues in the edible tissues of cattle sent to slaughter. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Swine must not be slaughtered for human consumption within 12 days of last treatment. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Source metadata:

https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals

Reported cases

Serious reports

Species represented

Grouped by Body System

Digestive (4) · Loss of appetite, Haemorrhagic diarrhoea, Diarrhea Neurologic (1) · Tiredness (lethargy) Effectiveness (2) · Lack of efficacy - NOS, Lack of efficacy (ectoparasite) - tick NOS Other (25) · Surgical site disorder, Shaking, Reluctant to move

Most Reported Reactions

Body system	Cases	Species	Serious cases
Neurologic	1	Cat	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Cat	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1

Species coverage: Dog (25) Cat (7)

View detailed reaction table

Body system	Species	Seriousness	Frequency	Reports
Neurologic	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Dog	Serious	-	1
Digestive	Cat	Serious	-	1
Other	Cat	Serious	-	1
Effectiveness	Dog	Non-serious	-	1
Effectiveness	Cat	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Digestive	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Dog	Serious	-	1
Digestive	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Digestive	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Serious	-	1

Source metadata:

https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2019-US-025839

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

No owner handouts linked yet.

Official label / PI

SPL

FOI

A-200489-C-0073-NL-AA_PI_2.pdf

Official label / PI · Labeling

Open original

N-137409-C-0125-NL-AA_PI.pdf

Official label / PI · Labeling

Open original

A-200781-C-0017-NL-AA_PI.pdf

Official label / PI · Labeling

Open original

A-200476-R-0049-CS-AA_PI.pdf

Official label / PI · Labeling

Open original

101-479

Official label / PI · EA

Open original

101-479

Official label / PI · FONSI

Open original

Flunazine®-S

SPL · SPL

Open original

FDA Structured Product Label

Flunazine®-S

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
ANADA: 200-489
Status: RX
Form: Injectable Solution
Route: Intramuscular
Species: No use class stated or implied

Composition / specifications

Each milliliter contains flunixin meglumine equivalent to 50 mg of flunixin.

Swine

Indication

For the control of pyrexia associated with swine respiratory disease.

Dosage

Administer 2.2 mg/kg (1 mg/lb; 2 mL per 100 lbs) body weight as a single intramuscular administration. The injection should be given only in the neck musculature with a maximum of 10 mL per site.

Limitations

For intramuscular use in swine. Not tor use in breeding swine.

Flunine-S™

SPL · SPL

Open original

FDA Structured Product Label

Flunine-S™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Cronus Pharma Specialities India Private Ltd.
ANADA: 200-791
Status: RX
Form: Injectable Solution
Route: Intramuscular

Composition / specifications

50 mg flunixin (equivalent to 83 mg flunixin meglumine) per mL

Swine

Indication

For the control of pyrexia associated with swine respiratory disease

Dosage

2.2 mg/kg (1 mg/lb; 2 mL per 100 lbs) body weight given by a single intramuscular administration. The injection should be given only in the neck musculature with a maximum of 10 mL per site.

Banamine® Paste

SPL · SPL

Open original

FDA Structured Product Label

Banamine® Paste

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 137-409
Status: RX
Form: Paste
Route: Oral
Species: Horse, Not For Meat Production

Composition / specifications

Each 30-gram syringe contains flunixin meglumine equivalent to 1,500 milligrams of flunixin.

Horses

Indication

For alleviation of inflammation and pain associated with musculoskeletal disorders.

Dosage

0.5 milligram of flunixin per pound of body weight daily.

Limitations

For oral use only. Treatment should not exceed 5 consecutive days. The effect of this drug on pregnancy has not been determined. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Flunine™

SPL · SPL

Open original

FDA Structured Product Label

Flunine™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Cronus Pharma Specialities India Private Ltd.
ANADA: 200-781
Status: RX
Form: Injectable Solution
Route: Intramuscular, Intravenous
Species: Dairy, excluding dry cows • No Use Class Stated Or Implied

Composition / specifications

50 mg/mL

Horses

Indication

For the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. It is also recommended for the alleviation of visceral pain associated with colic in the horse.

Dosage

The recommended dose for musculoskeletal disorders is 0.5 mg per pound (1 mL/100 lbs) of body weight once daily. Treatment may be given by intravenous or intramuscular injection and repeated for up to 5 days. The recommended dose for the alleviation of pain associated with equine colic is 0.5 mg per pound of body weight. Intravenous administration is recommended for prompt relief. Treatment may be repeated when signs of colic recur.

Cattle

Indication

For the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. It is also indicated for the control of inflammation in endotoxemia.

Dosage

The recommended dose for control of pyrexia associated with bovine respiratory disease and endotoxemia and control of inflammation in endotoxemia, is 1.1 to 2.2 mg/kg (0.5 to 1 mg/lb; 1 to 2 mL per 100 lbs) of body weight given by slow intravenous administration either once a day as a single dose or divided into two doses administered at 12-hour intervals for up to 3 days. The total daily dose should not exceed 2.2 mg/kg (1.0 mg/lb) of body weight. Avoid rapid intravenous administration of the drug. The recommended dose for acute bovine mastitis is 2.2 mg/kg (1 mg/lb; 2 mL per 100 lbs) of body weight given once by intravenous administration.

Flunixin Injection - S

SPL · SPL

Open original

FDA Structured Product Label

Flunixin Injection - S

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Norbrook Laboratories, Ltd.
ANADA: 200-476
Status: RX
Form: Liquid (Solution)
Route: Intramuscular
Species: No use class stated or implied

Label highlights

Indication

For the control of pyrexia associated with swine respiratory disease.

Dosage

The recommended dose for swine is 2.2 mg/kg (1 mg/lb; 2 mL per 100 lbs) body weight given by a single intramuscular administration. The injection should be given only in the neck musculature with a maximum of 10 mL per site

Limitations

Not for use in breeding swine. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Flu-Nix™

SPL · SPL

Open original

FDA Structured Product Label

Flu-Nix™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Huvepharma EOOD
ANADA: 200-061
Status: RX
Form: Liquid (Solution)
Route: Intramuscular, Intravenous
Species: Horse, Not For Meat Production • Beef And Dairy

Composition / specifications

Each mL contains flunixin meglumine equivalent to 50 mg flunixin.

Horses

Indication

For alleviation of inflammation and pain associated with musculoskeletal disorders and alleviation of visceral pain associated with colic.

Dosage

0.5 mg per pound of body weight per day, intravenously or intramuscularly, for up to 5 days.

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle (Beef and dairy)

Indication

For control of pyrexia associated with bovine respiratory disease, endotoxemia, and acute bovine mastitis. It is also indicated for the control of inflammation in endotoxemia.

Dosage

1.1 to 2.2 mg/kilogram (0.5 to 1.0 mg/lb) of body weight per day, as a single dose or divided into 2 doses administered at 12-hour intervals, intravenously, for up to 3 days.

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Banamine®

SPL · SPL

Open original

FDA Structured Product Label

Banamine® Banamine®-S

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 101-479
Status: RX
Form: Injectable Solution
Route: Intravenous, Intramuscular
Species: Horse, Not For Meat Production • Beef, excluding breeding bulls • Dairy, excluding dry dairy cows and breeding bulls • Calves, excluding veal calves

Composition / specifications

The drug contains 50 milligrams of flunixin per milliliter of aqueous solution.

Horses

Indication

For alleviation of inflammation and pain associated with musculoskeletal disorders, and alleviation of visceral pain associated with colic.

Dosage

0.5 mg per pound of body weight per day, intravenously or intramuscularly, for up to 5 days.

Limitations

Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle

Indication

For control of pyrexia associated with bovine respiratory disease, acute bovine mastitis, and endotoxemia. Also indicated for control of inflammation in endotoxemia.

Dosage

1. 1 to 2.2 mg/kilogram (0.5 to 1.0 mg/lb) of body weight per day, as a single dose or divided into 2 doses administered at 12-hour intervals, intravenously, for up to 3 days (control of pyrexia associated with bovine respiratory disease and endotoxemia and control of inflammation in endotoxemia).

2. 2mg/kg (1.0 mg/lb) of body weight given once by intravenous administration for control of pyrexia associated with acute bovine mastitis.

Limitations

Do not slaughter for human consumption within 4 days of last treatment. A withdrawal period has not been established for use in preruminating calves. Do not use in calves to be processed for veal. Do not use in dry dairy cows. Milk that has been taken during treatment and for 36 hours after the last treatment must not be used for food. Approved only for intravenous administration in cattle. Intramuscular administration has resulted in violative residues in the edible tissues of cattle sent to slaughter. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Banamine®-S

SPL · SPL

Open original

FDA Structured Product Label

Banamine® Banamine®-S

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 101-479
Status: RX
Form: Injectable Solution
Route: Intravenous, Intramuscular
Species: Horse, Not For Meat Production • Beef, excluding breeding bulls • Dairy, excluding dry dairy cows and breeding bulls • Calves, excluding veal calves

Composition / specifications

The drug contains 50 milligrams of flunixin per milliliter of aqueous solution.

Horses

Indication

For alleviation of inflammation and pain associated with musculoskeletal disorders, and alleviation of visceral pain associated with colic.

Dosage

0.5 mg per pound of body weight per day, intravenously or intramuscularly, for up to 5 days.

Limitations

Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle

Indication

For control of pyrexia associated with bovine respiratory disease, acute bovine mastitis, and endotoxemia. Also indicated for control of inflammation in endotoxemia.

Dosage

2. 2mg/kg (1.0 mg/lb) of body weight given once by intravenous administration for control of pyrexia associated with acute bovine mastitis.

Limitations

Flunazine®

SPL · SPL

Open original

FDA Structured Product Label

Flunazine®

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
ANADA: 200-581
Status: RX
Form: Paste
Route: Oral
Species: No Use Class Stated Or Implied

Composition / specifications

30 grams of paste contains flunixin meglumine equivalent to 1,500 mg of flunixin.

Label highlights

Indication

For the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse

Dosage

0.5 mg per pound of body weight per day for up to 5 days

Limitations

For oral use in horses only. Treatment should not exceed 5 consecutive days. The effect of flunixin meglumine on pregnancy has not been determined. Federal law restricts this drug to use by or on the order of a licensed veterinarian

Flunazine™

SPL · SPL

Open original

FDA Structured Product Label

Flunazine™

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Bimeda Animal Health Limited
ANADA: 200-387
Status: RX
Form: Liquid (Solution)
Route: Intravenous, Intramuscular
Species: Beef And Dairy • No Use Class Stated Or Implied

Composition / specifications

<span style="font-size: 10.5pt; font-family: Verdana; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-family: 'Times New Roman'">Each mL of solution contains flunixin meglumine equivalent to 50 mg flunixin.</span>

Cattle

Indication

For the control of pyrexia associated with bovine respiratory disease, endotoxemia, and acute bovine mastitis.

Dosage

1.1 to 2.2 mg/kg (0.5 to 1 mg/lb; 1 to 2 mL per 100 lbs) body weight given by slow intravenous administration, either once a day as a single dose, or divided into two doses at 12-hour intervals for up to 3 days; for control of pyrexia associated with bovine respiratory disease and endotoxemia and control of inflammation in endotoxemia. 2.2 mg/kg (1.0 mg/lb; 2 mL per 100 lbs) of body weight given once by intravenous administration for acute bovine mastitis.

Limitations

The total daily dose should not exceed 2.2 mg/kg (1.0 mg/lb) of body weight. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Do not use in calves to be processed for veal. Do not use in dry dairy cows.

Horses

Indication

For the alleviation of inflammation and pain associated with musculoskeletal disorders, and alleviation of visceral pain associated with colic.

Dosage

0.5 mg per pound of body weight per day, intravenously or intramuscularly, for up to 5 days.

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Flunixin Meglumine Solution

SPL · SPL

Open original

FDA Structured Product Label

Flunixin Meglumine Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Zoetis Inc.
ANADA: 200-142
Status: RX
Form: Liquid (Solution)
Route: Intramuscular, Intravenous
Species: Horse, Not For Meat Production

Composition / specifications

The drug contains 50 milligrams of flunixin per milliliter of aqueous solution.

Horses

Indication

For alleviation of inflammation and pain associated with musculoskeletal disorders, and alleviation of pain associated with colic.

Dosage

0.5 mg per pound (/lb) of body weight per day, intravenously or intramuscularly, for up to 5 days.

Limitations

Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Flunixin Meglumine Injection

SPL · SPL

Open original

FDA Structured Product Label

Flunixin Meglumine Injection

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Elanco US Inc.
ANADA: 200-124
Status: RX
Form: Liquid (Solution)
Route: Intravenous, Intramuscular
Species: Beef And Dairy • No Use Class Stated Or Implied

Composition / specifications

<pre><span style="font-size: 10.5pt; font-family: Verdana; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-family: 'Times New Roman'">Each mL of solution contains flunixin meglumine equivalent to 50 mg flunixin. </span></pre><p> 

Horses

Indication

For the alleviation of inflammation and pain associated with musculoskeletal disorders, and alleviation of visceral pain associated with colic.

Dosage

0.5 mg per pound of body weight once daily, intravenously or intramuscularly, for up to 5 days.

Limitations

Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cattle

Indication

For control of pyrexia associated with acute bovine mastitis.

Dosage

2.2 mg/kg (1.0 mg/lb; 2 mL per 100 lb) of body weight given once by intravenous administration.

Limitations

Do not use in calves to be processed for veal. Do not use in dry dairy cows. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Indication

For control of pyrexia associated with bovine respiratory disease and endotoxemia. Also indicated for the control of inflammation in endotoxemia.

Dosage

1.1 to 2.2 mg/kg (0.5 to 1.0 mg/lb; 1 to 2 mL per 100 lb) of body weight per day, as a single dose or divided into 2 doses administered at 12-hour intervals, intravenously, for up to 3 days.

Limitations

Do not use in calves to be processed for veal. Do not use in dry dairy cows. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Banamine® Granules

SPL · SPL

Open original

FDA Structured Product Label

Banamine® Granules

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor: Intervet, Inc.
NADA: 106-616
Status: RX
Form: Top Dressing In Feed
Route: Oral
Species: Horse, Not For Meat Production

Composition / specifications

Each 10-gram packet contains flunixin meglumine equivalent to 250 milligrams of flunixin.

Horses

Indication

For alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.

Dosage

0.5 milligram of flunixin per pound of body weight (one packet per 500 pounds) per day.

Limitations

Administer daily dose for up to 5 days by sprinkling on small amount of feed. The effect of this drug on pregnancy has not been determined. Not for use in horses intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.